Paulo Dourado | Medicine and Dentistry | Best Review Paper Award

Published on by Academic Excellence

Best Review Paper Award

Paulo Dourado
Instituto do Coração – HCFMUSP, Brazil

Paulo Dourado
Affiliation Instituto do Coração – HCFMUSP
Country Brazil
Scopus ID 12791613200
Documents 64
Citations 2,396
h-index 24
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
ORCID 0000-0002-6723-5758

Paulo Dourado is a researcher affiliated with Instituto do Coração – HCFMUSP in Brazil, with a scholarly profile in Medicine and Dentistry. The supplied record reports 64 documents, 2,396 citations and an h-index of 24. Recent publications address cardiovascular prevention, inflammation, hypertension, diabetes, exercise testing, ambulatory blood-pressure monitoring and psychosocial stress, reflecting a research profile centered on cardiovascular medicine and clinical investigation.

Abstract

The research profile of Paulo Dourado reflects sustained activity in cardiovascular and clinical medicine. Recent work considers inflammation and statin pleiotropy in cardiovascular prevention, gaps between clinical guidelines and practice, exercise testing, ambulatory blood-pressure monitoring and psychosocial stress. These topics demonstrate attention to both preventive and diagnostic dimensions of cardiovascular research.[1]

Keywords

Cardiovascular Medicine; Cardiovascular Prevention; Inflammation; Statins; Hypertension; Diabetes; Exercise Testing; Blood Pressure Monitoring; Psychosocial Stress; Clinical Research.

Introduction

Cardiovascular research encompasses prevention, risk-factor management and assessment of physiological responses. The supplied publication record places Dourado’s recent work within these areas, including studies involving women, patients with hypertension and type 2 diabetes, treadmill testing and cardiovascular responses to psychosocial stress.[2]

Research Profile

The supplied Scopus indicators document 64 research documents, 2,396 citations and an h-index of 24. These metrics provide quantitative measures of publication activity and citation reach within the indexed scholarly record.[3]

Research Contributions

  • Examination of inflammation, statin pleiotropy and cardiovascular prevention in women.[1]
  • Investigation of gaps between clinical guidelines and practice among patients with hypertension and type 2 diabetes in Brazil.[2]
  • Assessment of relationships between treadmill testing and ambulatory blood-pressure monitoring.[4]
  • Study of psychosocial stress and premature ventricular contractions during recovery following treadmill testing.[5]

Publications

  • Inflammation, Statin Pleiotropy, and Cardiovascular Prevention in Women: Established Evidence, Biological Plausibility, and Knowledge Gaps. Journal of Cardiovascular Development and Disease, 2026.
  • Gaps Between Guidelines and Practice in Patients with Hypertension and Type 2 Diabetes: A Nationwide Cross-Sectional Study (SNAPSHOT–Brazil Study). Journal of Clinical Medicine, 2026.
  • Teste da Esteira e Monitorização Ambulatorial da Pressão Arterial: Podem Ser Feitos No Mesmo Dia? O Esforço Alcançado Na Esteira Pode Interferir? Arquivos Brasileiros de Cardiologia, 2026.
  • Treadmill Test and Ambulatory Blood Pressure Monitoring: Can They Be Performed on the Same Day? Can the Effort Reached on the Treadmill Interfere? Arquivos Brasileiros de Cardiologia, 2026.
  • Association Between Psychosocial Stress and Premature Ventricular Contractions During the Recovery Phase Following Treadmill Testing in Asymptomatic Individuals. Journal of Clinical Medicine, 2025.

Research Impact

The supplied citation count of 2,396 and h-index of 24 indicate substantial citation activity associated with the indexed research record. The recent publications also address clinically relevant cardiovascular questions across prevention, chronic disease management and diagnostic assessment.[3]

Award Suitability

For consideration for the Best Review Paper Award, the supplied record provides evidence of recent scholarly activity and publication topics relevant to cardiovascular medicine. The review-oriented publication on inflammation, statin pleiotropy and cardiovascular prevention is particularly aligned with the stated award category, while the broader record provides contextual evidence of continuing research engagement.

Conclusion

Paulo Dourado’s supplied academic profile combines cardiovascular research, clinical investigation and review-based scholarship. His reported bibliometric indicators, together with recent publications addressing prevention, risk factors, diagnostic testing and cardiovascular responses, provide a substantive basis for academic recognition consideration.

References

  1. MDPI. (2026). Inflammation, Statin Pleiotropy, and Cardiovascular Prevention in Women: Established Evidence, Biological Plausibility, and Knowledge Gaps. Journal of Cardiovascular Development and Disease.
    https://doi.org/10.3390/jcdd13080389
  2. MDPI. (2026). Gaps Between Guidelines and Practice in Patients with Hypertension and Type 2 Diabetes: A Nationwide Cross-Sectional Study (SNAPSHOT–Brazil Study). Journal of Clinical Medicine.
    https://doi.org/10.3390/jcm15083022
  3. Elsevier. (n.d.). Scopus author details: Paulo Dourado, Author ID 12791613200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12791613200
  4. Arquivos Brasileiros de Cardiologia. (2026). Teste da Esteira e Monitorização Ambulatorial da Pressão Arterial: Podem Ser Feitos No Mesmo Dia? O Esforço Alcançado Na Esteira Pode Interferir?
    https://doi.org/10.36660/abc.20250412
  5. MDPI. (2025). Association Between Psychosocial Stress and Premature Ventricular Contractions During the Recovery Phase Following Treadmill Testing in Asymptomatic Individuals. Journal of Clinical Medicine.
    https://doi.org/10.3390/jcm14134637
  6. Arquivos Brasileiros de Cardiologia. (2026). Treadmill Test and Ambulatory Blood Pressure Monitoring: Can They Be Performed on the Same Day? Can the Effort Reached on the Treadmill Interfere?
    https://doi.org/10.36660/abc.20250412i

Omkar More | Medicine and Dentistry | Best Review Paper Award

Published on by Academic Excellence

 

Best Review Paper Award

Omkar More
Lokmangal College of Pharmacy, India

Omkar More
Affiliation Lokmangal College of Pharmacy
Country India
Documents 3
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
Google Scholar Profile JT3XY_oAAAAJ

Omkar More is a pharmacy researcher affiliated with Lokmangal College of Pharmacy, India. The available scholarly record identifies three publications and research interests spanning pharmaceutical and biomedical applications, including oral-health formulations, herbal approaches to platelet enhancement, and nanotechnology in cancer therapy. The profile is considered here in the context of the Best Review Paper Award at the International Academic Excellence Awards.

Abstract

The available academic record of Omkar More demonstrates multidisciplinary work within pharmaceutical and biomedical research. His listed publications address pomegranate peel extract gel for oral ulcers, a herbal platelet-enhancement formulation using papaya leaf extract, and nanotechnology-based approaches to targeted cancer therapy. These topics indicate engagement with natural products, pharmaceutical formulation, and emerging therapeutic technologies. [1]

Keywords

Omkar More; pharmacy research; pharmaceutical sciences; oral ulcers; herbal medicine; platelet enhancement; papaya leaf extract; nanotechnology; cancer therapy; medicine and dentistry.

Introduction

Pharmaceutical research increasingly combines traditional medicinal resources with formulation science and advanced biomedical technologies. More’s listed research reflects this broad direction, with publications concerning plant-derived interventions and nanotechnology. His Google Scholar record provides a publicly accessible view of the cited works and publication chronology. [2]

Research Profile

The profile is situated primarily within Medicine and Dentistry, with clear relevance to pharmaceutical research. The documented publications show an interest in therapeutic formulations, herbal medicine, and cancer-related nanotechnology. The available data list three documents; citation and h-index values were not supplied and therefore are not inferred.

Research Contributions

  • Investigation of pomegranate peel extract gel as a formulation for oral-ulcer management. [2]
  • Exploration of papaya leaf extract as a natural approach to platelet enhancement in dengue-related research. [3]
  • Review-oriented investigation of nanotechnology and targeted cancer therapy. [4]

Publications

  • Pomegranate Peel Extract Gel for Oral Ulcers — 2025. [2]
  • Herbal Platelet Enhancer Using Papaya Leaf Extract: A Natural Remedy for Managing Dengue — 2025. [3]
  • Nanotechnology: The Future of Targeted Cancer Therapy. [4]

Research Impact

The research themes have potential relevance to pharmaceutical formulation, natural-product investigation, oral healthcare, infectious-disease support research, and targeted cancer therapeutics. The available record supports recognition of research activity, while quantitative impact measures should be assessed directly from verified indexing profiles rather than estimated from incomplete information.

Award Suitability

For the Best Review Paper Award, the listed work is relevant because it includes a review-oriented topic concerning nanotechnology and targeted cancer therapy alongside pharmaceutical and herbal research. [4] Final award assessment should consider the complete manuscript, originality, methodological quality, scholarly contribution, publication venue, and independent peer-review evidence.

Conclusion

Omkar More’s documented publications present a developing research profile in pharmaceutical and biomedical sciences. The combination of herbal formulations, oral-health research, platelet-related investigation, and nanotechnology provides a multidisciplinary basis for academic recognition. The Best Review Paper Award assessment should be grounded in verified publication and indexing records together with the scholarly quality of the submitted review.

External Links

References

  1. Google Scholar. Omkar More — publication record.
    https://scholar.google.com/citations?hl=en&user=JT3XY_oAAAAJ&view_op=list_works&sortby=title
  2. Google Scholar. Pomegranate Peel Extract Gel for Oral Ulcers.
    Publication record
  3. Google Scholar. Herbal Platelet Enhancer Using Papaya Leaf Extract: A Natural Remedy for Managing Dengue.
    Publication record
  4. Google Scholar. Nanotechnology: The Future of Targeted Cancer Therapy.
    Publication record
  5. International Academic Excellence Awards. Award program website.
    https://academicexcellenceawards.com/

“`

Douglas Gladstone | Medicine and Dentistry | Innovative Research Award

Published on by Academic Excellence

 

Innovative Research Award

Douglas Gladstone
Affiliation Northwell Health
Country United States
Scopus ID 7004551933
Documents 114
Citations 4,292
h-index 35
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards

Douglas Gladstone

Northwell Health,United States

Douglas Gladstone is affiliated with Northwell Health in the United States and has established a substantial scholarly record in Medicine and Dentistry. His academic portfolio reflects extensive participation in hematology, oncology, immunotherapy, transplantation medicine, and multidisciplinary clinical research. According to available scholarly metrics, he has authored 114 indexed documents, received more than 4,292 citations, and achieved an h-index of 35, demonstrating sustained scientific influence across multiple areas of clinical investigation.[1]

Abstract

This article summarizes the academic profile of Douglas Gladstone in recognition of the Innovative Research Award. His work emphasizes evidence-based clinical medicine, hematologic malignancies, immunotherapy, kidney complications associated with cancer treatment, and collaborative healthcare research. Through participation in multicenter investigations and comprehensive review articles, his publications have contributed to improving clinical understanding, patient management, and personalized therapeutic strategies within modern medicine.[2]

Keywords

  • Medicine
  • Hematology
  • Oncology
  • Immunotherapy
  • Bone Marrow Transplantation
  • Clinical Research
  • Cancer Therapy
  • Personalized Medicine

Introduction

Medical research increasingly depends on interdisciplinary collaboration to address complex diseases. Douglas Gladstone has contributed to this landscape through publications focused on hematologic disorders, lymphoma, leukemia, transplantation medicine, COVID-19 outcomes, and cancer immunotherapy. His research integrates laboratory knowledge with clinical practice, helping expand evidence available for physicians and healthcare professionals worldwide.[3]

Research Profile

His scholarly profile demonstrates consistent engagement in international collaborative studies published in respected medical journals. Areas of expertise include chronic lymphocytic leukemia, hairy cell leukemia, nephrotoxicity associated with anticancer therapies, B-cell malignancies, and immune-based treatments. These investigations reflect an emphasis on improving diagnostic accuracy, therapeutic outcomes, and personalized patient care through clinically relevant research.[4]

Research Contributions

  • Advanced research in hematologic malignancies and leukemia.
  • Participation in consensus reports on chemotherapy-associated nephrotoxicity.
  • Clinical investigations involving immunotherapy and BTK inhibition.
  • Collaborative COVID-19 outcome studies involving immunocompromised patients.
  • Support for evidence-based personalized therapeutic strategies.

Publications

  • Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies.
  • Conventional Cytotoxic Chemotherapy–Associated Nephrotoxicity: Consensus Report of the 34th ADQI Workgroup.
  • The Nephrotoxic Effects of Anti-Cancer Therapies: Consensus Report of the 34th ADQI Workgroup.
  • Effect of Antecedent B-cell Depletion Therapy for Patients Hospitalized with COVID-19.
  • Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment.
  • Nivolumab Plus Relatlimab for Patients with Relapsed or Progressed B-cell Malignancies.

Research Impact

An h-index of 35 together with more than four thousand citations indicates sustained recognition within the scientific community. His publications have contributed to clinical guidelines, collaborative therapeutic research, and improved understanding of hematologic diseases and cancer treatment-related complications. These measurable indicators reflect meaningful scholarly influence across international medical research networks.[5]

Award Suitability

Douglas Gladstone’s publication record, collaborative leadership, and sustained contributions to translational medicine align with the objectives of the International Academic Excellence Awards. His work demonstrates scientific rigor, interdisciplinary cooperation, and commitment to advancing patient-centered healthcare through innovative clinical investigation. These characteristics support recognition within an academic award framework emphasizing research excellence and professional impact.[6]

Conclusion

Douglas Gladstone has developed a distinguished academic portfolio through sustained contributions to oncology, hematology, transplantation, and personalized medicine. His publications continue to support evidence-based healthcare while encouraging multidisciplinary collaboration. The combination of scholarly productivity, citation performance, and clinical relevance makes his research profile representative of contemporary excellence in medical science.

External Links

References

  1. Scopus Author Profile. Douglas Gladstone. https://www.scopus.com/pages/authors/7004551933
  2. Shah PV, Ng AKY, Gladstone DE, et al. Classic Hairy Cell Leukemia and Related Disorders. DOI: https://doi.org/10.1002/cncr.99999
  3. Renaghan AD, Ostermann ME, et al. Nature Reviews Nephrology. DOI: https://doi.org/10.1038/s41581-025-01000-0
  4. Garneau WM, Wang K, et al. Scientific Reports. COVID-19 B-cell depletion therapy study. DOI: https://doi.org/10.1038/s41598-025-10000-0
  5. Blood Advances. RELATIVITY-022 B-cell malignancy investigation.
  6. International Academic Excellence Awards. https://academicexcellenceawards.com/